FOX vs NRIX · P/E 13, rev $16.30B vs rev $54.5M
Fox Corp Class B (FOX) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the FOX and NRIX stock pages for the full models.
Not investment advice.